UCB, Inc. et al v. Hikma Pharmaceuticals PLC et al
| Delaware District Court | |
| Case #: | 1:25-cv-00382 |
| Nature of Suit | 835 Property Rights - Patent – Abbreviated New Drug Application |
| Cause | 35:271 Patent Infringement |
| Case Filed: | Mar 28, 2025 |
| Last checked: Friday Mar 28, 2025 12:12 PM EDT |
|
Defendant
Hikma Pharmaceuticals PLC
|
|
|
Defendant
Hikma Pharmaceuticals USA Inc.
|
|
|
Plaintiff
Hananja EHF
|
Represented By
|
|
Plaintiff
UCB Biopharma SRL
|
Represented By
|
|
Plaintiff
UCB, Inc.
|
Represented By
|
|
Plaintiff
University of Iceland
|
Represented By
|
| Docket last updated: 03/31/2025 11:59 PM EDT |
| Friday, March 28, 2025 | ||
| 8 | 8
service
Summons Issued
Fri 03/28 12:08 PM
Summons Issued as to Hikma Pharmaceuticals PLC and Hikma Pharmaceuticals USA Inc. on 3/28/2025.(jfm) |
|
|
Att: 1
Summons Issued, Hikma Pharmaceuticals PLC
|
||
| 7 | 7
misc
Disclosure Statement - Rule 7.1
Fri 03/28 12:06 PM
Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed - filed by University of Iceland. (jfm) |
|
| 6 | 6
misc
Disclosure Statement - Rule 7.1
Fri 03/28 12:05 PM
Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate UCB SA, Other Affiliate UCB, Inc., Other Affiliate UCB Manufacturing Inc., Other Affiliate UCB Pharma SA for UCB Biopharma SRL; Other Affiliate UCB SA, Other Affiliate UCB Holdings Inc. for UCB, Inc. - filed by UCB Biopharma SRL, UCB, Inc. (jfm) |
|
| 5 | 5
misc
Disclosure Statement - Rule 7.1
Fri 03/28 12:01 PM
Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed for Hananja EHF - filed by Hananja EHF. (jfm) |
|
| 4 | 4
misc
Patent/Trademark Report to Commissioner of Patents
Fri 03/28 11:59 AM
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,217,033 B2; 8,809,322 B2; 9,289,432 B2; 9,687,495 B2. (jfm) |
|
| 3 | 3
misc
ANDA Form
Fri 03/28 11:57 AM
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 02/25/2025. Date of Expiration of Patent: 01/18/2028. Thirty Month Stay Deadline: 8/25/2027. (jfm) |
|
| 2 | 2
misc
Magistrate Consent Forms
Fri 03/28 11:56 AM
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) |
|
| 1 | 1
19
pgs
cmp
Complaint
Fri 03/28 11:55 AM
COMPLAINT for Patent Infringement against Hikma Pharmaceuticals PLC, Hikma Pharmaceuticals USA Inc. (Filing fee $ 405, receipt number ADEDC-4648415) - filed by UCB, Inc., UCB Biopharma SRL, Hananja EHF, University of Iceland.(jfm) |
|
|
Att: 1
Exhibits A-D,
|
||
|
Att: 2
Civil Cover Sheet
|
||